Ernexa Therapeutics Inc.

ERNA | NASDAQ

Price Alert Chart Builder DCF Calculator

$3.96

+$0.13 (+3.39%)

At close: Sep 21, 2026, 4:00 PM ET

$3.85

-$0.11 (-2.78%)

Pre-market: Sep 22, 2026, 4:22 AM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Market Data

Market Cap $1.2M

Enterprise Value $-3.44M

Beta 2.62

Average Volume 2.09M

Shares Outstanding (Diluted) 1.18M

Shares Change YoY 471.06%

Institutional Ownership 18.05%

Exchange NASDAQ

ISIN US1140824079

Price Performance

Price Change 1M -18.5%

Price Change 3M -35.9%

Price Change 6M -24.9%

Price Change YTD -86.3%

Price Change 1Y -86.9%

Price Change 3Y -99.5%

Price Change 5Y -100.0%

1M CAGR (ann.) -12.2%

1Y CAGR (ann.) -87.0%

5Y CAGR (ann.) -86.7%

All-Time CAGR -46.4%

Valuation

PE Ratio -0.21

Forward PE N/A

PEG Ratio -0.00

Forward PEG 0.00

PS Ratio N/A

Forward PS N/A

PB Ratio 0.39

P/FCF Ratio -0.11

P/Adj. FCF Ratio -0.10

P/OCF Ratio -0.53

EV/Sales N/A

EV/EBIT 0.25

EV/EBITDA 0.20

EV/FCF 0.31

Earnings Yield -476.0%

FCF Yield -895.9%

Adj. FCF Yield -998.0%

Financial Health

Net Cash $4.68M

Total Debt $349K

Cash & Short-Term Investments $5.03M

Total Assets $6.32M

Current Ratio 2.01

Quick Ratio 2.01

Debt / Equity Ratio 0.11

Debt / EBITDA -0.02

Debt / FCF -0.03

OCF / Debt -31.81

Interest Coverage -378.61

Altman Z-Score -62.89

Piotroski F-Score 3

Margins & Profitability

Gross Profit Margin 0.0%

Operating Profit Margin 0.0%

EBITDA Margin 0.0%

Net Profit Margin 0.0%

FCF Margin N/A

Adj. FCF Margin N/A

SBC / Revenue 0.0%

SBC Impact (per share) -11.4%

Returns

Return on Assets -194.1%

Return on Equity -305.9%

Return on Invested Capital -328.1%

Return on Capital Employed -346.9%

Return on Tangible Assets -194.1%

Historical Growth (CAGR)

Revenue CAGR 3Y -37.4%

Revenue CAGR 5Y 37.5%

Revenue CAGR 10Y -36.2%

EPS CAGR 3Y 48.8%

EPS CAGR 5Y 68.4%

EPS CAGR 10Y 21.1%

FCF CAGR 3Y 20.2%

FCF CAGR 5Y 17.8%

FCF CAGR 10Y -21.8%

Analyst Forecasts

Analyst Rating Hold

Analyst Count 0

EPS Growth Next 3Y 30.8%

Revenue Growth Next 3Y N/A

Earnings Date N/A

EPS Estimate (next Q) N/A

EPS Growth Est (next Q) N/A

Revenue Est (next Q) N/A

Revenue Growth Est (next Q) N/A

Cash Flow

Operating Cash Flow $-11.1M

Free Cash Flow $-11.14M

Adj. Free Cash Flow $-12.42M

FCF Per Share -$7.50

OCF Per Share -$7.47

OCF/S Ratio 0.0%

Income Statement

Revenue $0

Gross Profit $-86K

Operating Income $-11.74M

EBITDA $-17.56M

Net Income $-12.27M

EPS (Diluted) -$18.85

Revenue / Employee N/A

Profit / Employee $-2.45M

Employees 5